Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $39.8700 (-2.76%) ($38.7800 - $39.8700) on Fri. Oct. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.37% (three month average) | RSI | 12 | Latest Price | $39.8700(-2.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -7.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -13.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(63%) IBUY(62%) IWC(61%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.685% in a week (0% probabilities). VIXM(-33%) UUP(-16%) VXX(-12%) TBT(-8%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.685% (StdDev 5.37%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $26.3(-34.04%) | Resistance Level | $58.48 | 5 Day Moving Average | $46.71(-14.64%) | 10 Day Moving Average | $52.67(-24.3%) | 20 Day Moving Average | $58.48(-31.82%) | To recent high | -45.3% | To recent low | 1.6% | Market Cap | $2.476b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |